What is the global market size of Multimodal Imaging Market?

Multimodal Imaging Market size was valued at USD 2.17 billion in 2019 and is poised to grow from USD 2.26 billion in 2023 to USD 3.17 billion by 2031, growing at a CAGR of 4.3% in the forecast period (2024-2031). in the forecast period (2023-2030).

Who are the key vendors in the Multimodal Imaging Market?

Multimodal Imaging Market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Siemens Healthineers AG', 'General Electric Company (GE Healthcare)', 'Koninklijke Philips N.V.', 'Canon Medical Systems Corporation', 'Fujifilm Holdings Corporation', 'Bruker Corporation', 'Hologic, Inc.', 'Carestream Health, Inc.', 'Esaote SpA', 'Samsung Electronics Co., Ltd.', 'Hitachi, Ltd.', 'Shimadzu Corporation', 'PerkinElmer, Inc.', 'Toshiba Corporation', 'Agilent Technologies, Inc.', 'Carl Zeiss Meditec AG', 'Topcon Corporation', 'NIDEK Co., Ltd.', 'Bio-Rad Laboratories, Inc.', 'Mediso Ltd.', 'In April 2022, The purchase of Bartec Technologies Ltd, a UK-based company that specialises in the procurement, installation, and maintenance of Nuclear Medicine and Molecular Imaging equipment and accessories, was announced by Mediso Ltd.', 'In September 2022, The results of a groundbreaking study demonstrating the safety and efficacy of robotic-assisted neurovascular aneurysm embolization using the CorPath GRX Neurovascular System were presented today, according to an announcement made by A Siemens Healthineers Company, a leading developer of precision vascular robotics.'

What is the key driver of Multimodal Imaging Market?

In order to diagnose severe and chronic disorders, multimodal imaging technology is used. During the forecast period, it is anticipated that the rising prevalence of chronic conditions, such as cancers, cardiovascular diseases, and neurological diseases, will spur demand for medical equipment, including multimodal imaging systems. This, in turn, will propel the growth of the Multimodal Imaging market. Globally, the incidence of many respiratory diseases is rising, such as lung cancer, asthma, and chronic obstructive pulmonary disease (COPD), which will fuel the expansion of the worldwide multimodal imaging market throughout the forecast period. Due to the high cancer incidence, there is a rising demand for cancer screening and diagnosis, which is anticipated to propel the worldwide multimodal imaging market's expansion. Similar to this, it is anticipated that the prevalence of other chronic problems will rise, such as neurological disorders and cardiovascular diseases.

What is the key market trend for Multimodal Imaging Market?

The multimodal imaging market trend of technical developments in diagnostic imaging equipment is anticipated to have a favourable effect in the upcoming years. Multimodal imaging has seen a rise in technical improvements that are intended to enhance image quality, lower the overall cost of diagnostic procedures, and deliver accurate diagnoses with better patient care. In-depth R&D efforts are being made by a number of manufacturers to create cutting-edge multimodal imaging solutions. The creation of portable and handheld technology, 5D ultrasound technology, and breakthroughs in digital X-rays with wireless DR detectors are a few examples of such advancements. Doctors may now make more accurate diagnoses thanks to the development of three-dimensional (3D), four-dimensional (4D), and five-dimensional (5D) technology in multimodal imaging. Multimodal imaging technology firms are continually enhancing their product lines and implementing cutting-edge technologies like cloud computing and artificial intelligence (AI). The multimodal imaging market will expand as a result of these technical developments.

Which region accounted for the largest share in Multimodal Imaging Market?

North America is anticipated to dominate the multimodal imaging market as a whole Throughout the forecast period. The high frequency of chronic illnesses including cancer and cardiovascular diseases in the area, as well as well-established insurance policies and the availability of cutting-edge healthcare infrastructure, are some of the major factors responsible for the market's growth. Due to factors such an expanding senior population and a sizable patient pool, the United States has the greatest market share in the North American area, which is expected to drive up demand. The market for imaging systems is booming in the wake of the fast adoption of technologically improved imaging systems and the rising prevalence of chronic diseases.

Multimodal Imaging Market Size

SkyQuest Technology's Multimodal imaging market size, share and forecast Report is based on the analysis of market data and Industry trends impacting the global Multimodal Imaging Market and the revenue of top companies operating in it. Market Size Data and Statistics are based on the comprehensive research by our Team of Analysts and Industry experts.

Multimodal Imaging Market Insights

Multimodal Imaging Market size was valued at USD 4.1 Billion in 2023 and is poised to grow from USD 4.33 Billion in 2024 to USD 6.65 Billion by 2032, growing at a CAGR of 5.6% during the forecast period (2025-2032).

The multimodal imaging market growth is expected to be driven by continuous improvements in imaging technology, with a rise in resolution, acquisition speed, and sensitivity. Such advancements have increased the accuracy and resolution in the images, thus optimizing the possibilities of diagnosis and planning in the process of treatment. It will contribute much to the growth of the multimodal imaging market. Improvements and developments in cutting-edge technology by investing companies help enhance the performance of multimodal imaging products. Furthermore, research institutions are rapidly expanding the application of multimodal imaging in research work. For instance, the company, Siemens Healthineers, provides in-depth information regarding structure and function to allow superior research on matters of cancer and neurology. With people advancing in years, there is an increased predictability of them experiencing various medical conditions, and the requirement for diagnostic tests will be bound to rise. As about age-related disorders such as cancer and neurological diseases, the multimodal imaging industry has grown because of its ability to enable in-depth understanding, thus making it an essential tool pertaining to present healthcare needs of an aging population. The market is further propelled by government efforts, financing programs, and favorable rules concerning reimbursement. Funding initiatives and favorable reimbursement policies from global governments are promoting new imaging technology development and application. These policies are also beneficial for the market; they encourage health care providers to acquire multimodal imaging equipment.

US Multimodal Imaging Market is poised to grow at a sustainable CAGR for the next forecast year.

Multimodal Imaging Market Report Snapshots

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?

REQUEST FREE CUSTOMIZATION

FAQs

The established medical equipment companies and emerging companies determine the competitive landscape of the multimodal imaging sector. Industry players, including GE Healthcare, Siemens Healthcare, Philips Healthcare, and Canon Medical Systems with the high-tech imaging solutions dominate a huge market share. The R&D spending in these firms is considerable to come up with innovations in imaging technology and to provide improved system integration. Strategic elements also include alliances, acquisitions, joint ventures with medical facilities, academic institutions, and IT firms to increase market share and promote innovation. 'GE Healthcare ', 'Koninklijke Philips N.V. ', 'Canon Medical Systems Corporation ', 'Siemens Healthineers ', 'Zeiss Group ', 'Bruker ', 'Mediso Ltd. ', 'Neusoft Corporation ', 'Infraredx, Inc. (part of Nipro Corporation) ', 'Topcon Corporation ', 'Shanghai United Imaging Healthcare Co., Ltd. ', 'Heidelberg Engineering ', 'Spectrum Dynamics Medical ', 'Minfound Medical Systems Co., Ltd. ', 'Kindsway Biotech ', 'Sofie Biosciences, Inc. ', 'Fujifilm Corporation.', 'In October 2022, Spectrum Dynamics announced its latest development in digital nuclear medicine imaging: the ability to image with solid-state detector technology in a wide-bore, 3600-CZT based SPECT/CT configuration to detect high energy isotopes. The new generation VERITON-CT 400 Series Digital SPECT/CT scanners offer the possibility of opening both imaging applications in the heart, brain, and whole body. ', 'In April 2022, Mediso Ltd. acquired Bartec Technologies Ltd., a UK-based business, which has specializing business in the sales, installation, and maintenance of nuclear medicine and molecular imaging equipment and accessories. The acquisition will strengthen the position of the company within the UK and Ireland markets. However, financial details are not disclosed. ', 'In July 2021, Topcon Corporation has announced the acquisition of VISIA Imaging S.r.l. It is an ophthalmic imaging company whose headquarters are found in the suburbs of Florence, Italy.'

The global health network is gradually shifting focus on preventive treatment by designing ways to achieve better results while reducing costs. More vigilance on early disease detection is gradually becoming important, mainly attributed to multimodal imaging that allows both functional and anatomical assessments. This often helps to further diagnose such issues like cancer, neurological conditions, and cardiovascular conditions in at-risk populations early. This is coupled with early diagnosis trend, besides the progress in medical studies.

Diagnostics in the Remote Area and Telemedicine: Multimodal imaging is slowly being integrated into telemedicine and remote diagnostic platforms. The image data may now be safely transmitted to experts to analyze and diagnose from a remote location due to the growing utilization of digital healthcare technologies. Telemedicine allows for this possibility and avenue for faster consultations, greater accessibility to advanced imaging, and improved patient outcomes in disadvantaged regions. This imaging modality gains greater access to rural and isolated areas due to the telemedicine trend on the rise.

North America accounted for the highest multimodal imaging market share in 2022 and is predicted to be one of the spearheading regions in the forecast period as well. The market for this region is witnessing growth due to the presence of many prominent companies, including Siemens, GE Healthcare, and Koninklijke Philips N.V., in the region, along with advancements in technologies used for manufacturing multimodal imaging devices. The market is anticipated to grow due to the increasing adoption of advanced multimodal imaging technologies and the presence of a well-established healthcare infrastructure. The demand for multimodal imaging equipment also increased in the region because of the high health awareness from the public and the healthcare professionals about the importance of early diagnosis using imaging technologies.